The FDA granted accelerated approval to Voceryq to reduce surgeries in adults with recurrent respiratory papillomatosis, based on a 32-patient trial.
Novel Therapy Lands Speedy Approval For Wart-Like Airway Disease
Browsing Category
Medical Science
222 posts
What Happens When You Have A Stroke At 25
The Atlantic’s headline raises questions about stroke in young adults, but its article body and supporting details are unavailable.
Pancreatic Cancer Vaccine; AI Collaboration For Managing Epilepsy
A Texas Tech podcast reviewed early KRAS vaccine findings in pancreatic cancer and an AI-and-EEG approach to managing uncontrolled epilepsy.
Injections For Achilles Tendinopathy Flop In Randomized Trial
A randomized trial found high-volume Achilles injections did not outperform sham at 12 months; steroid shots offered temporary relief but worse midterm scores.
Fenebrutinib May Curb Chronic Active Lesions In Multiple Sclerosis
Phase III MRI analyses found less slowly expanding lesion growth with fenebrutinib in relapsing and primary progressive MS, but PRL results varied.
Lyme Disease Vaccine Candidate Just Misses Its Mark In Late-Stage Trial
LB6V showed 73.2% efficacy in the evaluable analysis but missed the trial’s preset threshold; a modified analysis narrowly cleared it.
Obesity In Young Adults Linked To Multiple Early Cancers
A South Korean study of 6.3 million adults found higher cancer incidence with greater BMI, with associations persisting into middle age.
Moderna And Merck Say Their mRNA Cancer Vaccine Cut Death, Recurrence By 42%
A Phase 3 trial found personalized mRNA vaccine intismeran plus Keytruda reduced the two-year risk of melanoma recurrence or death versus Keytruda alone.
Remibrutinib Cuts Multiple Sclerosis Relapse Rates In Phase III Trials
Two Phase III trials found lower annualized relapse rates with remibrutinib than teriflunomide in relapsing MS; disability results were mixed.
Medicare Is More Broken Than We Thought
A report says at least 2 million seniors will receive notices that their Medicare Advantage plans are ending, with replacement choices varying by area.
